Inmunoterapia Celular
SCIENTIFIC AREA
Inmunology
Center
Hospital Universitario Fundación Jiménez Díaz
VACANCIES
1
CONTACT E-MAIL
beatriz.antonio@quironsalud.es
DESCRIPTION OF THE OFFER
The group develops CAR-T cell therapies to treat patients with hematological maligancies and also solid tumors.
The candidate will collaborate enhancing the persistence of different CAR-T cells for the treatment of Non-Hodgkin Lymphoma patients based on CD79b and BCMA targets.
The impact of chemotherapy-induced senescence on the persistence of CAR-T cells will be analyzed in the different treatment CAR options based on CD79b and BCMA.
GROUP'S WEBSITE
MASTER
Biomolecules & Cell D.
SUPERVISOR TFM
Beatriz Martin Antonio